Home » Topics » BioWorld Science

BioWorld Science
RSS

Study indicates ISIS-3521/CGP-64128A inhibits tumor growth

Aug. 23, 1996

Imutec/NaPro BioTherapeutics sign research agreement

Aug. 23, 1996

C242-DM1: Promising new approach to colorectal cancer treatment

Aug. 23, 1996

MDX-210 efficacy/safety trial begins in U.K.

Aug. 23, 1996

IDEC-Y2B8/IDEC-C2B8 combination undergoes phase I/II

Aug. 23, 1996

Progenic's GMK undergoes phase III clinical trials

Aug. 23, 1996

AltaRex awaits Canadian approval to begin Ovarex phase II/III trials

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

Fareston launched in the U.K.

Aug. 23, 1996

Phase I pharmacokinetic study of asulacrine initiated

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026